Last Updated: August 9, 2026

Roche Company Profile

✉ Email this page to a colleague

What is the competitive landscape for ROCHE

ROCHE has sixty-one approved drugs.

Summary for Roche

US Patents:	0
Tradenames:	49
Ingredients:	45
NDAs:	61

Drugs and US Patents for Roche

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Roche	TEGISON	etretinate	CAPSULE;ORAL	019369-001	Sep 30, 1986		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Roche	COPEGUS	ribavirin	TABLET;ORAL	021511-001	Dec 3, 2002		DISCN	Yes	No		⤷ Start Trial				⤷ Start Trial
Roche	TARACTAN	chlorprothixene	CONCENTRATE;ORAL	016149-002	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Roche

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Roche	MENRIUM 5-4	chlordiazepoxide; estrogens, esterified	TABLET;ORAL	014740-004	Approved Prior to Jan 1, 1982	4,316,897	⤷ Start Trial
Roche	KYTRIL	granisetron hydrochloride	INJECTABLE;INJECTION	020239-002	Mar 11, 1994	5,952,340	⤷ Start Trial
Roche Palo	TICLID	ticlopidine hydrochloride	TABLET;ORAL	019979-001	Mar 24, 1993	4,591,592	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for ROCHE drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	For Oral Suspension	200 mg/mL	➤ Subscribe	2011-03-25
➤ Subscribe	Capsules	30 mg and 45 mg	➤ Subscribe	2011-08-02
➤ Subscribe	Injection	0.1 mg/mL, 1 mL single dose vial	➤ Subscribe	2007-03-08
➤ Subscribe	Injection	1 mg/mL, 4 mL multi-dose vials	➤ Subscribe	2004-07-19
➤ Subscribe	Tablets	2.5 mg and 150 mg	➤ Subscribe	2007-05-16
➤ Subscribe	Capsule	75 mg	➤ Subscribe	2010-11-15
➤ Subscribe	Oral Suspension	6 mg/mL	➤ Subscribe	2015-06-18
➤ Subscribe	Injection	1 mg/mL, 1 mL vials	➤ Subscribe	2004-06-01
➤ Subscribe	Injection	1 mg/mL, 3 mL Vial	➤ Subscribe	2007-08-31

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.